Health Care & Life Sciences » Biotechnology | XTL Biopharmaceuticals Ltd.

XTL Biopharmaceuticals Ltd.

XTL Biopharmaceuticals Ltd. ADR
Stock Exchange NASDAQ Stock Market
EPS
$1.17
Market Cap
$9.72 M
Shares Outstanding
5.14 M
Public Float
-

Profile

Address
5 Badner Sreet
Ramat Gan HM 4365603
Israel
Employees -
Website http://www.xtlbio.com
Updated 07/08/2019
XTL Biopharmaceuticals Ltd is a biopharmaceutical company, which engages in the acquisition and development of pharmaceutical drugs. Its drug development program focuses on the treatment of systemic lupus erythematosus. The company was founded on March 9, 1993 and is headquartered in Raanana, Israel.

Financials

View All
Created with Highcharts 5.0.14XTL Biopharmaceuticals Ltd. ADRNet Income. Fiscal year is January-December. All values ILS Thousands.8 9378 9377 5807 58014 07214 0729 7699 7692 8092 80910 73510 73520132014201520162017201802.5k5k7.5k10k12.5k15k
Created with Highcharts 5.0.14XTL Biopharmaceuticals Ltd. ADRSales/Revenue. Fiscal year is January-December. All values ILS Thousands.8 5508 550000000002 8512 85120132014201520162017201802k4k6k8k10k

Shlomo Spokone Shalev
Chairman
Alexander Rabinovitch
Non-Executive Director